Search Within

Natasha Rekhtman

Formats
  1. Meeting Abstract (209)
  2. Journal Article (180)
  3. Book Section (20)
  4. Review (16)
  5. Correspondence (3)
  6. Editorial (3)
  7. Book Whole (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (434)
  2. Department of Medicine (222)
  3. Solid Tumor Oncology Division (220)
  4. GSK Faculty (210)
  5. Thoracic Oncology (210)
  6. Human Oncology and Pathogenesis Program (157)

More Groups

People
  1. William Travis (193)
  2. Marc Ladanyi (134)
  3. Charles Rudin (96)
  4. Jason Chang (90)
  5. Mark Kris (66)
  6. Gregory Riely (65)

More People

Years
  1. 2025 (20)
  2. 2024 (22)
  3. 2023 (18)
  4. 2022 (33)
  5. 2021 (42)
  6. 2020 (37)

More Years

Publications
  1. Journal of Thoracic Oncology (82)
  2. Modern Pathology (74)
  3. Laboratory Investigation (70)
  4. Journal of Clinical Oncology (31)
  5. Archives of Pathology & Laboratory Medicine (17)
  6. Clinical Cancer Research (15)

More Publications

Publishers
  1. Elsevier Inc. (88)
  2. Nature Publishing Group (83)
  3. Nature Research (74)
  4. American Society of Clinical Oncology (38)
  5. American Association for Cancer Research (32)
  6. College of American Pathologists (17)

More Publishers

Results (434)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Validation of PTEN and c-MET status in small biopsy material and cytology for pulmonary adenocarcinoma
    Meeting Abstract

    Pandya, D.; Jungbluth, A.; Rekhtman, N.; Moreira, A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • HNF4 α is a marker for invasive mucinous adenocarcinoma (IMA) and a prognostic factor in stage I lung adenocarcinoma (LADC)
    Meeting Abstract

    Eguchi, T.; Kadota, K.; Leduc, C.; Rekhtman, N.; Moreira, A.; Jones, D. R.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive mutation analysis of never-smokers with small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Won, H.; Krug, L. M.; Varghese, A. M.; Riely, G. J.; Rekhtman, N.; Wang, L.; Travis, W. D.; Zakowski, M.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis
    Journal Article

    Kadota, K.; Nitadori, J.; Rekhtman, N.; Jones, D. R.; Adusumilli, P. S.; Travis, W. D.
    American Journal of Surgical Pathology (2015)

    Fulltext@MSK | Save
  • Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)
    Meeting Abstract

    Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Response to crizotinib and cabozantinib in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P. K.; Drilon, A. E.; Yu, H. A.; Krug, L. M.; Rekhtman, N.; Borsu, L.; Ginsberg, M. S.; Berger, M. F.; Ladanyi, M.; Rudin, C. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Litvak, A. M.; Drilon, A. E.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P. K.; Kris, M. G.; Riely, G. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save